The Jerusalem PostIDF chief vows to apply October 7 lessons, pledges to pursue Israel's enemies at military ceremonyESPNFollow live: Ramirez's error paves way for Rays' rallyESPN DeportesMemo Ochoa tendrá homenaje en el Azteca (Banorte)CNN Türkİzmir’de gıda zehirlenmesi şüphesi: 80 işçi hastane kaldırıldıZDF heuteEntdecken Sie das ZDF-Nachrichtenstudio한겨레살아있다면 초등학생일 정인이…‘정인나무’는 훌쩍 자라있었다UOLMoro reúne 230 prefeitos e quase 3 mil pessoas em evento pró-Flávio em CuritibaCNN BrasilSeleção Brasileira feminina vacila e cede empate à Argentina em amistosoNew Straits TimesPerak to prioritise local water needs before supplying Penang - Exco경향신문태백시, 공원묘원 봉안당 추가 조성···1만1184기 수용 규모La NaciónCómo va Boca vs. Vasco Da Gama, por las semifinales de la Copa SudamericanaEl ComercioResultados ONPE en región Ica al 98.110 %: revisa aquí el conteo oficial de las Elecciones Regionales y Municipales 2026
The Daily Newsstand · Free, Always
Wednesday, October 14, 2026

Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says

Translate

“The extensive record compiled by FTC staff shows that Mr. Shkreli chose to blatantly disregard the order after leaving prison,” FTC Commissioner Mark Meador said in a statement. “Among other actions, he has traded pharmaceutical stocks and actively sought to influence the business and management of multiple pharmaceutical companies through public commentary, in violation of the terms of the injunction. … A lifetime industry ban is only effective if breaches are met with consequences commensurate with the seriousness of the order.”

In a response, Shkreli said he was surprised by the FTC’s filing. “I could see totalitarian NY AG Letitia James trying to limit a citizen’s free speech but not from Trump’s FTC,” he wrote on social media.

“Magic trick”

The brief filed by the FTC and the states breaks down Shkreli’s alleged violations in four phases:

(1) a 2022 trading competition with another YouTuber; (2) shorting a small biotech firm in 2024, along with trading in other Pharmaceutical Company stocks; (3) a 2025 trading challenge in which he shorted three small biotech firms along with trading in many other Pharmaceutical Company stocks; and (4) a trading challenge begun in June 2026 with a $10,000,000 account in which he is again trading in Pharmaceutical Company stocks.

In numerous livestreams on various social media platforms, Shkreli would sometimes show his accounts on screen, the filing said. He discussed pharmaceutical companies at length, evaluating stocks and predicting the outcomes of pivotal clinical trials. In 2025, he told his viewers about his “magic trick,” saying: “It doesn’t matter what trades I make because I can always find a couple of biotech stocks to smoke.” Later in the year, Shkreli advised his viewers to short one pharmaceutical company’s stock, and the company’s stock price quickly dropped 17 percent.

The FTC and the states wrote in their filing that the stocks Shkreli discussed in livestreams are “likely the tip of the iceberg.” FTC staff only reviewed a fraction of Shkreli’s social media activity, and Shkreli has made several references to other accounts he has.

“I have some other accounts that I’[d] show you, but, like, I know feds are watching, so f[*]ck that,” he said, according to the filing.

View the original on Ars Technica →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.